S9788 modulation of P-glycoprotein- and multidrug-related protein-mediated multidrug resistance by Servier 9788 in doxorubicin resistant MCF7 cells

被引:20
作者
Bichat, F
Solis-Recendez, G
Poullain, MG
Poupon, MF
Khayat, D
Bastian, G
机构
[1] Lab Serv Oncol Med Pitie Salpetriere, F-75013 Paris, France
[2] Inst Curie, UMR 147, Paris, France
[3] IRI Servier, Courbevoie, France
基金
澳大利亚研究理事会;
关键词
doxorubicin resistance; MDR; MRP; MDR-sensitization; MCF7;
D O I
10.1016/S0006-2952(98)00007-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Inherent or acquired resistance to multiple natural drugs, termed multidrug resistance (MDR), represents a major obstacle to chemotherapy. Expression of P-glycoprotein (P-gp) in MCF7mdr and MCF7R resistant cells was detected by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot analysis. MCF7R, but not the MDR1 gene-transfected MCF:mdr cells, expressed multidrug-related protein (MRP) concomitantly. Efficacy of an MDR modulator, designated as Servier 9788 (S9788), was estimated by doxorubicin (Dox) sensitization, Dox incorporation, and functional rhodamine 123 assay on MCF7 cell lines. Results showed that S9788 modulates the P-gp-associated MDR of MCF7mdr cells as well as the Multidrug-related protein-associated MDR of MCF7R cells. BIOCHEM PHARMACOL 56;4:497-502, 1998. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:497 / 502
页数:6
相关论文
共 23 条
[1]  
Abbaszadegan MR, 1996, CANCER RES, V56, P5435
[2]  
[Anonymous], 1983, J IMMUNOL METH
[3]   ADDING A REVERSER (VERAPAMIL) TO COMBINED CHEMOTHERAPY OVERRIDES RESISTANCE IN SMALL-CELL LUNG-CANCER XENOGRAFTS [J].
ARVELO, F ;
POUPON, MF ;
BICHAT, F ;
GROSSIN, F ;
BOURGEOIS, Y ;
JACROT, M ;
BASTIAN, G ;
LECHEVALIER, T .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (11) :1862-1868
[4]  
Bichat F, 1997, ANTICANCER RES, V17, P3393
[5]  
CASS CE, 1989, CANCER RES, V49, P5788
[6]   CYTOFLUORESCENCE LOCALIZATION OF ADRIAMYCIN IN RESISTANT COLON CANCER-CELLS [J].
CHAUFFERT, B ;
MARTIN, F ;
CAIGNARD, A ;
JEANNIN, JF ;
LECLERC, A .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 13 (01) :14-18
[7]   P-GLYCOPROTEIN POSSESSES A 1,4-DIHYDROPYRIDINE-SELECTIVE DRUG ACCEPTOR SITE WHICH IS ALLOSERICALLY COUPLED TO A VINCA-ALKALOID-SELECTIVE BINDING-SITE [J].
FERRY, DR ;
RUSSELL, MA ;
CULLEN, MH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 188 (01) :440-445
[8]  
FISHERSZAFARZ B, 1981, ANAL BIOCHEM, V110, P165
[9]  
FORD JM, 1990, PHARMACOL REV, V42, P155
[10]  
GERVASONI JE, 1991, CANCER RES, V51, P4955